[PDF] Top 20 Teses jurídicas dos tribunais superiores: Direito Comercial
Has 10000 "Teses jurídicas dos tribunais superiores: Direito Comercial" found on our website. Below are the top 20 most common "Teses jurídicas dos tribunais superiores: Direito Comercial".
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy.
... The anti-tumor effects associated with oncolytic virus therapy are mediated significantly 29.. through immune-mediated mechanisms which depends both on the type of v[r] ... See full document
43
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumor therapy
... As seen in Fig.5, the triple therapy GM-CSF/Reovirus innate immune mediated, 252 C8+T Th1lo + VSV-ASMEL boost CD4+ Th17, Th1lo + anti-PD-1 Th1 and Th17 253 enhancement was significantly [r] ... See full document
140
Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade
... single-agent checkpoint blockade ...vaccines, oncolytic viruses, immune cell co-stimulatory agonists (CD137 (4-1BB), CD134 (OX40), glucocorticoid-induced TNF receptor (GITR), and CD40), ... See full document
26
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy)
... Combining oncolytic therapy with checkpoint inhibitors An immune-active tumour microenvironment and type I IFN transcriptional signature are associated with clinical benefit from immunotherapy ... See full document
5
Different Levels of Immunogenicity of Two Strains of Fowlpox Virus as Recombinant Vaccine Vectors Eliciting T-Cell Responses in Heterologous Prime-Boost Vaccination Strategies
... two separate recombinant antigens and multiple, rather than single, independent viral clones derived from the two ...heterologous prime-boost vaccination regimens using individual clones of ... See full document
95
Recombinant Viruses for Cancer Therapy
... on viruses encoding tumor-specific antigens, boost anti-cancer immune responses by enhanced presentation of the tumor antigens to immune ...on viruses encoding tumor-specific antigens, ... See full document
7
Oncolytic virus immunotherapy: future prospects for oncology
... variable anti- genic exposure ...theory, oncolytic vi- ruses can affect the antigenic profile of the injected tissue by inducing not only an anti-tumor immune response but also an anti-viral ... See full document
64
T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy
... an anti-PD1/PD-L1 induced immune checkpoint blockade, and thus is an important parameter in determining the outcome of an immune checkpoint blockade ...immune checkpoint ... See full document
28
Targeting immune checkpoints in breast cancer: an update of early results
... an anti-PD-L1, is currently under eval- uation in a neoadjuvant phase I/II trial in combination with nab-paclitaxel and dose-dense doxorubicin plus cyclophosphamide for stage I–III TNBC (NCT02489448) ... See full document
21
Dynamics of a mathematical model for cancer therapy with oncolytic viruses
... cancer therapy with oncolytic viruses that incorporates the time needed for infected tumor cells to produce new virions af- ter viral entry, the probability of surviving during the latent period, and ... See full document
14
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.
... Committee. For fig. S1, six- to 10-week old C57/BL6 mice (Jackson Laboratories) were injected intracranially with 1x10 5 B16 melanoma cells and eight days later treated with a single injection of 1x10 8 PFU i.v. reovirus ... See full document
21
<p>Cervical Cancer: Emerging Immune Landscape and Treatment</p>
... Immune therapy is one of the most promising breakthroughs in cancer ...PD-1/PD-L1 blockade seems to be a potential treatment approach for CC, though the toxicities of current immune therapy will ... See full document
8
Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells
... by using Alamar Blue (Invitrogen, Waltham, MA) which is added at 10% of the sample volume followed by 4–16 h ...lated using the formula; %Lysis = 100 × {[(AF of targets alone)] − [(AF of mix) − (AF of ... See full document
10
The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
... to checkpoint inhibition (Tables 1, ...to checkpoint blockade, increased representation of baseline Bacteroidetes phylum (includes Bacteroides fra- gilis) in melanoma patients and intestinal ... See full document
13
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
... with anti-CTLA-4 antagonist mAb resulted in tumor rejec- tion, suggesting that removing T cell co-inhibitory signal was an effective approach to treat cancer ...humanized anti-CTLA-4 mAb (ipilimumab) showed ... See full document
10
Central nervous system toxicities of anti-cancer immune checkpoint blockade
... steroids. Anti-N-Methyl- D-aspartate receptor antibodies were documented in the CSF of this patient who showed no clinical improvement with 1,000 mg of daily methylprednisolone or intravenous immunoglobulin but ... See full document
10
Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunity
... aCTLA-4 antibody does not impair thymic negative selection of TRP-1 TCR Tg T cells. In our working model, we hypothesized that Aire deficiency and aCTLA-4 antibody have additive antimelanoma effects due to their function ... See full document
12
Oncolytic virus and PD-1/PD-L1 blockade combination therapy
... Abstract: Oncolytic viruses are lytic for many types of cancers but are attenuated or repli- cation-defective in normal ...lysis, oncolytic viruses can induce host immune responses against ... See full document
45
The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model.
... induce tumour growth delay in preclinical mouse tumour models, such as models of prostate cancer, melanoma, colorectal adenocarcinoma and oral tongue squamous cell ...Moreover, using proteomic tools ... See full document
80
Combination Vascular Delivery of Herpes Simplex Oncolytic Viruses and Amplicon Mediated Cytokine Gene Transfer Is Effective Therapy for Experimental Liver Cancer
... To measure the cytotoxicity of G207, in vitro cyto- toxicity assays were performed. G207, HSV-IL2, mG207/HSV-IL2, or pG207/HSV-IL2 were added to subconfluent layers of CT-26 or Morris hepatoma cells in 12-well flat ... See full document
9
Related subjects